A meta-analysis to investigate the relation between fitzpatrick skin types and toleranility of adapalene-benzoyl peroxide topical get in subjects with mild or moderate acne

Journal of Clinical and Aesthetic Dermatology

Volumn 3, Issue 8, 2010, Pages 15-19

  Callender, Valerie D ^a   Preston, Norman ^a   Osborn, Cris ^a   Johnson, Lori ^a   Gottschalk, Ronald W ^b  

^a Callender Skin and Laser Center   (United States)

^b Galderma Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; EPIDUO; RETINOIC ACID; TAZAROTENE; UNCLASSIFIED DRUG;

ACNE; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRY SKIN; HUMAN; HYPERPIGMENTATION; MANTEL HAENSZEL TEST; META ANALYSIS; SKIN BURNING SENSATION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN PROTECTION; SKIN SURFACE; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 77957666610     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pawin H, Beylot C, Chivot M, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol. 2004;14(1):4-12.
2. Strauss JS, Thiboutot DM. Fitzpatrick's Dermatology in General Medicine. Vol 1. New York: McGraw-Hill; 1999.
3. Katsambas AD, Stefanaki C, Cunliffe WJ. Guidelines for treating acne. Clin Dermatol. 2004;22(5):439-444.
4. Norris JF, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118(5):651-659.
5. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-S37.
6. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1-S50.
7. Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184-195.
8. Callender VD. Considerations for treating acne in ethnic skin. Cutis. 2005;76(2 Suppl):19-23.
9. Terrell S, Aires D, Schweiger ES. Treatment of acne vulgaris using blue light photodynamic therapy in an African-American patient. J Drugs Dermatol. 2009;8(7):669-671.
10. Baumann L, Rodriguez D, Taylor SC, Wu J. Natural considerations for skin of color. Cutis. 2006;78(6 Suppl):2-19.
11. Alexis AF, Lamb A. Concomitant therapy for acne in patients with skin of color: a case-based approach. Dermatol Nurs. 2009;21(1):33-36.
12. Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(4):609-615, vii.
13. Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl):S98-S106.
14. Sagransky M, Yentzer BA, Feldman SR. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009;10(15):2555-2562.
15. Wolf JE, Jr. Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther. 2002;19(3): 109-118.
16. Brogden RN, Goa KE. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs. 1997;53(3):511-519.
17. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology. 1998;196(1):119-125.
18. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol. 1998;139(Suppl 52):3-7.
19. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997;36(6 Pt 2):S96-S103.
20. Halder RM. The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol. 1998;39(2 Pt 3):S98-S103.
21. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 Suppl):48-54.
22. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438-1443.
23. Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45-50.
24. Fanta D, Bardach H, Poitscheck C. Investigations on the bacteriostatic effect of benzoyl peroxide. Arch Dermatol Res. 1979;264(3):369-371.
25. Fulton JE, Jr., Farzad-Bakshandeh A, Bradley S. Studies on the mechanism of action to topical benzoyl peroxide and vitamin A acid in acne vulgaris. J Cutan Pathol. 1974;1(5):191-200.
26. Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27(1):17-24.
27. Waller JM, Dreher F, Behnam S, et al. "Keratolytic" properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol. 2006;19(5):283-289.
28. Fakhouri T, Yentzer BA, Feldman SR. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol. 2009;8(7):657-661.
29. Taylor SC. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002;46(2 Suppl):S41-S62.
30. Ho SG, Chan HH. The Asian dermatologic patient: review of common pigmentary disorders and cutaneous diseases. Am J Clin Dermatol. 2009;10(3):153-168.
31. Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57(5):791-799.
32. Gollnick HP, Draelos Z, Glenn MJ, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009;161(5):1180-1189.
33. Gold LS, Tan J, Cruz-Santana A, et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. 2009;84(2):110-116.
34. Czernielewski J, Poncet M, Mizzi F. Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris. Cutis. 2002;70(4):243-248.